Lipodistrophy: a paradigm for understanding the consequences of “overloading” adipose tissue

K Lim, A Haider, C Adams, A Sleigh… - Physiological …, 2021 - journals.physiology.org
Lipodystrophies have been recognized since at least the nineteenth century and, despite
their rarity, tended to attract considerable medical attention because of the severity and …

Familial partial lipodystrophy (FPLD): recent insights

C Bagias, A Xiarchou, A Bargiota… - … , Metabolic Syndrome and …, 2020 - Taylor & Francis
Lipodystrophies are a heterogeneous group of congenital or acquired disorders,
characterized by partial or generalized loss of adipose tissue. Familial partial lipodystrophy …

New classification and diagnostic criteria for insulin resistance syndrome

W Ogawa, E Araki, Y Ishigaki, Y Hirota… - Endocrine …, 2022 - jstage.jst.go.jp
This report of a working group established by the Japan Diabetes Society proposes a new
classification and diagnostic criteria for insulin resistance syndrome. Insulin resistance …

Lipodystrophies—disorders of the fatty tissue

B Knebel, D Müller-Wieland, J Kotzka - International Journal of Molecular …, 2020 - mdpi.com
Lipodystrophies are a heterogeneous group of physiological changes characterized by a
selective loss of fatty tissue. Here, no fat cells are present, either through lack of …

Insulin resistance and exaggerated insulin sensitivity triggered by single-gene mutations in the insulin signaling pathway

R Kushi, Y Hirota, W Ogawa - Diabetology international, 2021 - Springer
Whereas the genetic basis of insulin sensitivity is determined by variation in multiple genes,
mutations of single genes can give rise to profound changes in such sensitivity. Mutations of …

Clinical characteristics of insulin resistance syndromes: a nationwide survey in Japan

T Takeuchi, Y Ishigaki, Y Hirota… - Journal of Diabetes …, 2020 - Wiley Online Library
Abstract Aims/Introduction Insulin resistance syndrome (IRS) of type A or B is triggered by
gene abnormalities of or autoantibodies to the insulin receptor, respectively. Rabson …

A multicenter, open-label, single-arm trial of the efficacy and safety of empagliflozin treatment for refractory diabetes mellitus with insulin resistance (EMPIRE-01)

Y Hirota, Y Kakei, J Imai, H Katagiri, K Ebihara… - Diabetes Therapy, 2024 - Springer
Introduction Insulin resistance syndrome and lipoatrophic diabetes are characterized by
severe insulin resistance and are often refractory to treatment. Trials assessing the efficacy …

[HTML][HTML] SGLT2 inhibitors for genetic and acquired insulin resistance: Considerations for clinical use

Y Hosokawa, W Ogawa - Journal of Diabetes Investigation, 2020 - ncbi.nlm.nih.gov
Administration of an sodium–glucose cotransporter 2 inhibitor to individuals with insulin
resistance reduces the level of glucose disposal necessary to maintain glycemia as a result …

Familial partial lipodystrophy syndromes

A Fernández-Pombo, S Sánchez-Iglesias… - La Presse Médicale, 2021 - Elsevier
Lipodystrophies are a heterogeneous group of rare conditions characterised by the loss of
adipose tissue. The most common forms are the familial partial lipodystrophy (FPLD) …

Genotype-stratified treatment for monogenic insulin resistance: a systematic review

RK Semple, KA Patel, S Auh, RJ Brown - Communications medicine, 2023 - nature.com
Background Monogenic insulin resistance (IR) includes lipodystrophy and disorders of
insulin signalling. We sought to assess the effects of interventions in monogenic IR, stratified …